Skip to main content

Rhenman & Partners Asset Management AB

Position in NRIX — Nurix Therapeutics, Inc.

CIK 1599882 Stockholm, V7

Position in NRIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$16,599,905
+$11,740,655 QoQ
Shares Held
684,250
+118.3% QoQ
Ownership
0.659%
of shares outstanding
% of Portfolio
1.57%
of 13F equity value
Holder Rank
#38
of 210 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NRIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $335,352,902 across 39 Biotechnology names. NRIX ranks #4 (4.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NRIX
Nurix Therapeutics, Inc.
This page
684,250 $16,599,905

All Filings in NRIX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,599,905 684,250
2026-03-31 $4,859,250 313,500
2025-12-31 $10,196,375 537,500
2025-09-30 $3,210,900 347,500
2025-06-30 $2,107,150 185,000
2025-03-31 $2,962,111 249,336
2024-12-31 $5,463,600 290,000
2024-09-30 $6,741,000 300,000
2024-06-30 $3,639,581 174,393